Cedric Francois, Chief Executive Officer at Apellis Pharmaceuticals, Inc. (APLS), sold 13,431 shares at $65.00 ($873K) on 2024-01-22, disclosed to the SEC on 2024-01-23.
Seasonal sale ($873k) by Chief Executive Officer — this insider has traded APLS in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| APLS | SELL | 2026-01-15 | $226K | — | Filing → |
| APLS | SELL | 2025-08-29 | $12.7M | — | Filing → |
| APLS | SELL | 2025-07-18 | $797K | — | Filing → |